NasdaqCM - Nasdaq Real Time Price USD
Cassava Sciences, Inc. (SAVA)
1.8800
+0.0200
+(1.08%)
At close: May 14 at 4:00:00 PM EDT
1.8900
+0.01
+(0.53%)
Pre-Market: 9:18:13 AM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Richard Jon Barry | CEO, President & Director | 319.38k | -- | 1959 |
| Mr. Eric J. Schoen | Chief Financial Officer | 725k | -- | 1968 |
Cassava Sciences, Inc.
6801 N. Capital of Texas Highway
Suite 300 Building 1
Austin, TX 78731
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 30
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. Cassava Sciences, Inc. was formerly known as Pain Therapeutics, Inc. and changed its name to Cassava Sciences, Inc. in March 2019. The company was incorporated in 1998 and is based in Austin, Texas.
Corporate Governance
Cassava Sciences, Inc.’s ISS Governance QualityScore as of May 1, 2025 is 8. The pillar scores are Audit: 10; Board: 8; Shareholder Rights: 8; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
August 6, 2025 at 12:30 PM UTC - August 11, 2025 at 12:30 PM UTC
Cassava Sciences, Inc. Earnings Date
Recent Events
Related Tickers
AVXL Anavex Life Sciences Corp.
8.17
+0.62%
ANVS Annovis Bio, Inc.
1.6900
-0.59%
IOVA Iovance Biotherapeutics, Inc.
1.7050
-4.75%
BLUE bluebird bio, Inc.
4.9800
+50.45%
NVAX Novavax, Inc.
5.96
-3.72%
SRPT Sarepta Therapeutics, Inc.
35.74
-1.27%
HEPA Hepion Pharmaceuticals, Inc.
0.3180
0.00%
IBRX ImmunityBio, Inc.
2.4900
-0.80%
AXSM Axsome Therapeutics, Inc.
103.67
-1.89%
TNXP Tonix Pharmaceuticals Holding Corp.
22.08
+9.42%